Skip to main content

Hospitalization Among Patients With Atrial Fibrillation and a Recent Acute Coronary Syndrome or Percutaneous Coronary Intervention Treated With Apixaban or Aspirin: Insights From the AUGUSTUS Trial.

Publication ,  Journal Article
Vora, AN; Alexander, JH; Wojdyla, DM; Aronson, R; Granger, CB; Darius, H; Windecker, S; Mehran, R; Averkov, O; Budaj, A; Kong, DF; Kobalava, Z ...
Published in: Circulation
December 3, 2019

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Circulation

DOI

EISSN

1524-4539

Publication Date

December 3, 2019

Volume

140

Issue

23

Start / End Page

1960 / 1963

Location

United States

Related Subject Headings

  • Vitamin K
  • Treatment Outcome
  • Survival Analysis
  • Randomized Controlled Trials as Topic
  • Pyridones
  • Pyrazoles
  • Purinergic P2Y Receptor Antagonists
  • Prospective Studies
  • Proportional Hazards Models
  • Platelet Aggregation Inhibitors
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Vora, A. N., Alexander, J. H., Wojdyla, D. M., Aronson, R., Granger, C. B., Darius, H., … Lopes, R. D. (2019). Hospitalization Among Patients With Atrial Fibrillation and a Recent Acute Coronary Syndrome or Percutaneous Coronary Intervention Treated With Apixaban or Aspirin: Insights From the AUGUSTUS Trial. Circulation, 140(23), 1960–1963. https://doi.org/10.1161/CIRCULATIONAHA.119.043754
Vora, Amit N., John H. Alexander, Daniel M. Wojdyla, Ronald Aronson, Christopher B. Granger, Harald Darius, Stephan Windecker, et al. “Hospitalization Among Patients With Atrial Fibrillation and a Recent Acute Coronary Syndrome or Percutaneous Coronary Intervention Treated With Apixaban or Aspirin: Insights From the AUGUSTUS Trial.Circulation 140, no. 23 (December 3, 2019): 1960–63. https://doi.org/10.1161/CIRCULATIONAHA.119.043754.
Vora, Amit N., et al. “Hospitalization Among Patients With Atrial Fibrillation and a Recent Acute Coronary Syndrome or Percutaneous Coronary Intervention Treated With Apixaban or Aspirin: Insights From the AUGUSTUS Trial.Circulation, vol. 140, no. 23, Dec. 2019, pp. 1960–63. Pubmed, doi:10.1161/CIRCULATIONAHA.119.043754.
Vora AN, Alexander JH, Wojdyla DM, Aronson R, Granger CB, Darius H, Windecker S, Mehran R, Averkov O, Budaj A, Kong DF, Kobalava Z, Mehta RH, Mirza Z, Guimaraes PO, Parkhomenko A, Quadros A, Thiele H, Goodman SG, Lopes RD. Hospitalization Among Patients With Atrial Fibrillation and a Recent Acute Coronary Syndrome or Percutaneous Coronary Intervention Treated With Apixaban or Aspirin: Insights From the AUGUSTUS Trial. Circulation. 2019 Dec 3;140(23):1960–1963.

Published In

Circulation

DOI

EISSN

1524-4539

Publication Date

December 3, 2019

Volume

140

Issue

23

Start / End Page

1960 / 1963

Location

United States

Related Subject Headings

  • Vitamin K
  • Treatment Outcome
  • Survival Analysis
  • Randomized Controlled Trials as Topic
  • Pyridones
  • Pyrazoles
  • Purinergic P2Y Receptor Antagonists
  • Prospective Studies
  • Proportional Hazards Models
  • Platelet Aggregation Inhibitors